All Stories

  1. Epidemiology, outcome, and risk factors for infectious complications in myelofibrosis patients receiving ruxolitinib: A multicenter study on 446 patients

    Article • Hematological Oncology, April 2018, Wiley

    Massimiliano Bonifacio

  2. Recent Developments in Chronic Myeloid Leukemia Biology and Treatment

    Article • April 2018, Bentham Science Publishers

    Dr Claudio Sorio, Massimiliano Bonifacio

  3. Multiple large osteolytic lesions in a patient with systemic mastocytosis: a challenging diagnosis

    Article • Clinical Case Reports, October 2017, Wiley

    Massimiliano Bonifacio

  4. Efficacy and safety of ruxolitinib in intermediate-1 IPSS risk myelofibrosis patients: Results from an independent study

    Article • Hematological Oncology, May 2017, Wiley

    Massimiliano Bonifacio